JIR Secondary Antibodies for the Investigation of Bio-Nanotechnology in Healthcare Delivery
The importance of good secondary antibodies in understanding the effects of drug delivery vehicles
The importance of good secondary antibodies in understanding the effects of drug delivery vehicles
The AACR and the UBS oncology impact fund aim to use the new funding gift program to propel breakthroughs in cancer research and therapeutics
The test supports international guidelines for treating antibiotic resistant STI
This year’s research prize awarded by Eppendorf AG goes to Switzerland
This year’s research prize awarded by Eppendorf goes to Belgium
Marian Burducea discusses the main challenges encountered by a young researcher and the crucial need for science collaboration in a post-pandemic world
Explore topics from NGS and disinfectants in the food and beverage industry to high-resolution ion mobility mass spectrometry, and CAR-T cell sensitivity and persistence
SelectScience celebrates scientists at the forefront of cancer research, from liquid biopsies through cancer stem cells to drug delivery innovations
As we celebrate the first regulatory approval of a gene-editing based therapeutic, Casgevy™, for the treatment of sickle cell disease and transfusion-dependent β-thalassemia, we consider the gene-editing challenges that must be overcome before CRISPR gene-editing technology becomes a common treatment modality
Explore how a partnership between a lead researcher in sexual health and a molecular diagnostics innovator helped to overcome the therapeutic hurdles that come with antibiotic resistance
Scientists have inserted fungus genes into a yeast cell to make it produce penicillin molecules